LEO Pharma A/S

LEO Pharma A/S is a global pharmaceutical manufacturer specializing in medical dermatology and critical care, headquartered in Ballerup, Denmark. Established in 1908, the company researches, develops, and distributes prescription medicines for complex skin conditions such as chronic hand eczema, atopic dermatitis, psoriasis, and generalized pustular psoriasis. In addition to medical dermatology, LEO Pharma provides specialized therapies in critical care targeting thrombosis, nasopharyngeal carcinoma, and esophageal squamous cell carcinoma. The organization operates six state-of-the-art manufacturing facilities across Denmark, Ireland, France, and Italy to maintain a reliable global supply chain. Serving over 100 million patients annually across more than 70 countries, LEO Pharma partners with biotech companies, research institutions, and healthcare providers to advance clinical trials and expand its product pipeline. With over 4,000 employees worldwide, LEO Pharma continues to innovate first-in-class topical creams, biologics, and systemic treatments for patients globally.